The third round of the Medicare Drug Price Negotiation Program includes treatments for HIV and diabetes, among other conditions. The Centers for Medicare & Medicaid Services also released a list of the top 50 medications it deems strong candidates for future negotiations based on current prices and patient utilization.

There is limited research comparing HHUS and ABUS in second-look settings despite the fact that these exams are routinely utilized as supplemental imaging tools. 

Not all fat is created equal, and some specific types carry more neurological consequences than others, according to new research. 

Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.

The American Board of Cardiovascular Medicine is still pushing forward with its efforts to change how cardiologists are certified in the United States. While the group can reapply in the future for a standalone cardiology board, it is also looking at possible partnerships with other organizations.

The program is one of only a handful across the United States to offer students meaningful exposure to the field prior to beginning their official clinical training. 

The American Stroke Association's first major update in 7 years highlights the importance of coordinated care and expands patient access to critical treatments. It also includes the first detailed recommendations for treating stroke in pediatric patients.

More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.

Chris Waddell, a medtech executive focused on various structural heart technologies, is leaving Abbott after several years to "recharge" and pursue a new opportunity.

Danbury, Connecticut-based Advanced Imaging Specialists previously sued Trinity Health in November and is now prepared to vacate their contract amid ongoing challenges.